Preoperative Evaluation of Thyroid Epithelial Lesions by DNA Ploidy and Galectin-3 Expression in FNAC
DOI:
https://doi.org/10.3889/oamjms.2014.105Keywords:
Fine needle aspiration cytology, thyroid epithelial lesions, DNA ploidy, Galectin-3, immunohistochemistryAbstract
AIM: This study aimed to investigate the value of DNA ploidy and galectins-3 immunostain in the preoperative evaluation of thyroid epithelial lesions.
MATERIAL AND METHODS: Sixty patients presenting with thyroid enlargement were included in this study and referred by clinicians for FNA. Routine cytological evaluation was done on PAPÂ Â stained slides according to the WHO criteria and at least three slides were prepared for routine cytological examinations. The nuclear DNA analysis was performed at the Pathology Department, National Research Center using the Leica Qwin 500 Image Analyzer (LEICA Imaging Systems Ltd, Cambridge, England). Galectin-3 expression was investigated in all tissues using streptavidin-biotin technique.
RESULTS: Conventional Fine needle aspiration cytology (FNAC) of 60 cases could diagnose malignancy with a sensitivity of 60%, negative predictive value (NPV) 71.4%, and overall diagnostic accuracy of 80%. The aneuploidy was significantly associated with malignancy, with sensitivity 90.9%, specificity 83.3% and accuracy 88.3%. On using galectin-3 immunocytochemichal stain on cell blocks prepared from FNA the values were improved, sensitivity 93.3% specificity 86.7% and overall accuracy 90% and it was noticed that galectin-3 over expression was significantly associated with malignancy.
CONCLUSIONS: From the results of this study we can consider that DNA ploidy and Galectin-3 could refine the FNA results and increase its sensitivity as a screening test from sensitivity(60%) to reach sensitivity (93.3%), thus decreasing the false negative cases. From this study, it is concluded that the application of ancillary techniques as galectin-3 immunocytochemical markers may become a reliable indicator for surgical intervention, DNA ploidy measurements on the other hand may be of value in galectin-3 negative cases to determine the behavior of the lesion in such cases & refine the preoperative assessment by out ruling false negative cases.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Rosaria MR, Campenni A, Baldari S, Trovato M. What is new on thyroid cancer biomarkers. Biomarker Insights. 2008;3:237-252.
Utiger RD. The multiplicity of thyroid nodules and carcinomas. N Eng J Med. 2005;352: 2376-2378. DOI: https://doi.org/10.1056/NEJMp058061
Thapa PB, Shrestha D, Pradhananga JP. Correlation of fine needle aspiration cytology with histopathology findings in cases of thyroid lesions in Bir Hospital. Journal of college of medical science-Nepal. 2013; 9(1):23-29. DOI: https://doi.org/10.3126/jcmsn.v9i1.9670
Ogilvie JB, Piatigorsky EJ, Clark OH. Current status of fine needle aspiration for thyroid nodules. Adv Surg. 2006;40: 223-238.
Bahar G, Braslavsvy D, Sphpitcer T, Avidan S. The cytological and clinical value of thyroid “ follicular lesionsâ€. Otolaryngol. 2003; 24: 217-220. DOI: https://doi.org/10.1016/S0196-0709(03)00030-9
Nadjari B, Motherby H, Pooschke S, Gabbert HE, Simon D, Roher HD, Feldkamp J, Tharandt L, Bocking A. DNA aneuploidy as a specific marker of neoplastic cells in FNAB of the thyroid. Anal Quant Cytol Pathol. 1999; 21:481-488.
Frasoldati A, Flora M, Pesenti M, Caroggio A, Valcavi R. Computer- assisted cell morphometry and ploidy analysis in the assessment of thyroid follicular neoplasms. Thyroid. 2001; 11: 941-946.
Sturgis CD, Caraway NP, Johnston DA, Sherman SI, Kidd L, Katz RL. Image analysis of papillary thyroid carcinoma fine needle aspirates. Cancer. 1999; 87:155-160. DOI: https://doi.org/10.1002/(SICI)1097-0142(19990625)87:3<155::AID-CNCR9>3.0.CO;2-#
Haugen BR, Woodmansee WW, McDermott MT. Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumors. Clin Endocrinol (Oxf). 2002; 56:281-290.
Ringel M: Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma. Rev Endo Metab Dis. 2000; 1: 173-181.
Cohen Y, Rosenbaum E, Clark DP, Zeiger MA, Westra WH. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid nodules. Clin Can Rese. 2004;10:2761-2765. DOI: https://doi.org/10.1158/1078-0432.CCR-03-0273
Aron M, Kaplia K, Verma K. Utility of galectins-3 expression in thyroid aspirates as a diagnostic marker in differentiating bengin from malignant thyroid neoplasms. Indian J Pathol Microbiol. 2006;49: 376-380.
Kim MJ, Kim HJ, Hong SJ, Shong YK, Gong G. Diagnostic utility of galectins-3 in aspirates of thyroid follicular lesions. Acta Cytol. 2006; 50: 28-34. DOI: https://doi.org/10.1159/000325891
Saggiorato E, De Pompa R, Volante M, Cappia S, Arecco F, Orlandi F, Paptti M. Characterization of thyroid “follicular neoplasm†in fine needle aspiration cytological speciemens using a panel of immunohistochemical markers: a protocol for clinical application. Endocrine Related Canc. 2005;12: 305-317. DOI: https://doi.org/10.1677/erc.1.00944
Barotolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, K han A, Nardi F, Tecce R, Larsson O. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet. 2001;357:1644-1650. DOI: https://doi.org/10.1016/S0140-6736(00)04817-0
DeLellis RA, Lloyd RV, Heitz PU, Eng C (editors): World Health Organization Classification of Tumors: pathology and Genetics of Tumors of Endocrine Organs. Lyon, IARC Press, 2007.
Danque POV, Chen HB, Patil J, et al. Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparation. Mod Pathol. 1993; 6:270-275.
Onaran Y, Tezelman S, Gurel N, Teiziolgu T, Oguz H, Tanakol R, KapranY. The value of DNA content in predicting the prognosis of thyroid carcinoma in an iodine deficiency region. Acta chir belg. 1999;99:30-35. DOI: https://doi.org/10.1080/00015458.1999.12098437
Borget I, Vielh P, Leboulleux S, Allyn M, De Pouvourville G. Assessment of the cost of fine needle aspiration cytology as a diagnostic tool in patients with thyroid nodules. Am J Clin Pathol. 2008;129:763-771. DOI: https://doi.org/10.1309/H86KM785Q9KBWPW5
Ogilvie JB, Piatigorsky EJ, Clark OH. Current status of fine needle aspiration for thyroid nodules. Adv Surg. 2006;40: 223-238. DOI: https://doi.org/10.1016/j.yasu.2006.06.003
Marhefka GD, McDivitt JD, Shakir KM, Drake AJ. Diagnosis of follicular neoplasm in thyroid nodules by fine nmeedle aspiration cytology. Acta Cytol. 2009; 53: 517-523. DOI: https://doi.org/10.1159/000325378
Mehrotra P, Gonzalez M, Johnson SJ, Davis BR, Wilson JA. Mcm2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy. Laryngosc. 2006;116: 1434-1437. DOI: https://doi.org/10.1097/01.mlg.0000225931.59644.93
Deveci MS, Deveci G, LiVolsi VA, Baloch ZW. Fine needle aspiration of follicular lesions of the thyroid. Diagnosis and follow up. Cytojournal. 2006; 3:9-14. DOI: https://doi.org/10.1186/1742-6413-3-9
Durand S, Ferraro P, Selmi A, et al. Evaluation of gene expression profiles in thyroid nodule biopsy material to diagnose thyroid cancer. J Clin Endocriol Metab. 2008;93: 1195-1202. DOI: https://doi.org/10.1210/jc.2007-1571
Filie AC, Asa SL, Geisinger KR, et al. Utilization of ancillary studies in thyroid fine needle asoiration: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36: 438-441. DOI: https://doi.org/10.1002/dc.20831
Raba W, Kaser K, Nieideuh H. Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine needle aspiration aspiration. Thyroid. 200;10: 709-712. DOI: https://doi.org/10.1089/10507250050137806
Giles Y, Boztepe H, Taziolu T, Tezelinian S. The advantage of total thyroidectomy to avoid reoperation for incidental thyroid cancer in multinodular goiter. A Ch Surgi. 2004;139: 179-182. DOI: https://doi.org/10.1001/archsurg.139.2.179
Rago T, Fiorc E, Santini F, Romani R, Piagyi P, Vilti P. Male sex, single nodularity are associated with the risk of thyroid cancerin patients with nodular thyroid disease. Euro J Endocrinol. 2010;162: 763-770. DOI: https://doi.org/10.1530/EJE-09-0895
Lubiz CC, Faquin WC, Yang J, Hodin R, Stephen A. Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid. 2010;20: 25-31. DOI: https://doi.org/10.1089/thy.2009.0208
Pedamallu R, Pedamallu K. Incedience of occult carcinoma in multinodular goiter using histopathological findings. The Internet J Surgery. 2008;17. DOI: https://doi.org/10.5580/dbf
Tuille RM, Lemar H, Burch H. The utility of fine needle aspiration for diagnosis of carcinoma associated with MNG. Thyroid. 2009;8: 377-383.
Esmaili HA, Taghipour H. Fine-Needle Aspiration in the Diagnosis of Thyroid Diseases: An Appraisal in Our Institution. ISRN Pathology. 2012;912728. DOI: https://doi.org/10.5402/2012/912728
Siddiqui MA, Griffith KA, Michael CW, Pu RT. Nodule heterogeneity as shown by size differences between the targeted nodule and the tumor in thyroidectomy specimen: a cause for a false-negative diagnosis of papillary thyroid carcinoma on fine-needle aspiration. Cancer. 2008;25:27-33. DOI: https://doi.org/10.1002/cncr.23253
Flanagan MB, Ohori NP, Carty SE, Hunt JL. Repeat thyroid nodule fine-needle aspiration in patients with initial benign cytologic results. Am J Clin Pathol. 2006;125: 698-702. DOI: https://doi.org/10.1309/4AXLDMN1JRPMTX5P
Rosaria MR, Campenni A, Baldari S, Trovato M. What is new on thyroid cancer biomarkers? Biomarker Insights. 2008;3:237-252. DOI: https://doi.org/10.4137/BMI.S669
Faquin W. Diagnostic and reporting of follicular- patterned thyroid lesions by fine needle aspiration. Head Neck Pathol. 2009;3:82-85. DOI: https://doi.org/10.1007/s12105-009-0104-7
Yang J, Schnacling V, Logrono R. Fine needle aspiration of thyroid nodules: a study of 4703 patients with histologic correlations. Cancer. 2007;25: 306-315. DOI: https://doi.org/10.1002/cncr.22955
Haugan BR, Woodmansee WW, McDermott MT. Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumors. Clin Endocrinol (Oxf). 2002;56:281-290. DOI: https://doi.org/10.1046/j.1365-2265.2002.01500.x
Cochand–Priollet BK, outroumbus L, Mjalopouru T, Sivolaspenjo G. Discriminating benign from laignant thyroid lesions using artificial intelligence and statistical selection. Oncol Res. 2006;15: 1023-1026. DOI: https://doi.org/10.3892/or.15.4.1023
Hayashi N, Kitaoka M. Fine needle aspiration biopsy of the thyroid nodules: uses and limitations. Nippon Rinsho. 2007;65: 7.
Frasoldati A, Flora M, Pesenti M, Caroggio A, Valcavi R. Computer- assisted cell morphometry and ploidy analysis in the assessment of thyroid follicular neoplasms. Thyroid. 2001;11: 941-946. DOI: https://doi.org/10.1089/105072501753211000
Bakr MH, Mourad M, Agina HA. DNA ploidy, nuclear morphometry and ki67 proliferative index in the differentiation of thyroid follicular neoplasms. J Egy Soc Pathol. 2000;20: 117-124.
Nadjari B, Motherby H, Pooschke S, Gabbert HE, Simon D, Roher HD, Feldkamp J, Tharandt L, Bocking A. DNA aneuploidy as a specific marker of neoplastic cells in FNAB of the thyroid. Anal Quant Cytol Pathol. 1999;21:481-488.
Orell SR, Sterrett GF, Whitaker D. Thyroid gland. In: 'fine needle aspiration cytology' 4th edition. Elsevier Churchill livingstone, 2005:125-158.
Francia G, Azzolina L, Mantovani T, Davi MV, Brazzarola P, Valerio A, Petronio R, Sussi P. Heterogeneity of nuclear DNA pattern and its relationship with cell cycle activity parameters in multinodular goiter. Clin Endocrinol. 1997;46: 649-654. DOI: https://doi.org/10.1046/j.1365-2265.1997.1480961.x
Konarska L, Skierski L, Ellert A, Steinbrich J, Wozniak A, Kalczak M. Comparative studies of nuclear DNA content in benign and malignant thyroid lesions. Acta Biochim Poloni. 2001;48:783-793. DOI: https://doi.org/10.18388/abp.2001_3913
Camargo RS, Maeda MY, Shrata NK, Fiho AL. Is a Ag NOR and DNA ploidy analysis useful for evaluating thyroid neoplasms. Anal Quant Cytol Histol. 2005;27: 157-161.
Missaoui N, Hmissa S, Mokni M, Trabelsi A, Trimech M, Lagueb I, yacoubi MI, Sriha B, Korbi S. DNA content analysis in thyroid neoplasms: diagnostic and prognostic intrest. Ann endocrinol. 2005;66:333-339. DOI: https://doi.org/10.1016/S0003-4266(05)81790-1
Lewinski A. 2006. http://www.touchendocrinedisease.com/ significance-fine-needle-aspiration-a895-1.html DOI: https://doi.org/10.17925/EE.2006.00.02.1h
Cusick EL, Ewer SWB, Krukowski ZH, Matheson NA. DNA aneuploidy in follicular thyroid carcinoma. Brit J Surg. 2005;78:94-96. DOI: https://doi.org/10.1002/bjs.1800780129
Pennelli G, Mian C, Pelizzo MR, Naccamulli D. Galectin-3 Cytotest in Thyroid Follicular Neoplasia. Acta Cytologica. 2009; 53(5):7-13. DOI: https://doi.org/10.1159/000325381
Chiu CG, Strugnell SS, Griffith OL, Jones SJ, Gown AM, Walker B, Nabi IR, Wiseman SM. Diagnostic utility of galectin-3 in thyroid cancer. Am J Pathol. 2010;176(5):2067-81. DOI: https://doi.org/10.2353/ajpath.2010.090353
Aiad HA, Kandil MA, Asaad NY, Kased AM, El-gody S. Galectin-3 Immunostaining in Cytological and Histopathological Diagnosis of Thyroid Lesions . Journal of the Egyptian Nat. Cancer Inst. 2008;20: 36-46.
Oestreicher-Kedem Y, Halpern M, Roizman P, et al. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions. Head Neck. 2004;26: 960-966. DOI: https://doi.org/10.1002/hed.20087
Yoshii T, Inohara H, Takenaka Y, Honjo Y, Kubo T. Galectins-3 maintains the transformed phenotype of thyroid papillary carcinoma cells. Inter J Oncol. 2001;18: 787-792. DOI: https://doi.org/10.3892/ijo.18.4.787
Papotti M, Volante M, Saggiorato E, Orlandi F. Role of galectins-3 immunodetection in cytological diagnosis of thyroid cystic papillary carcinoma. Eur J Endocrinol. 2005;147: 515-521. DOI: https://doi.org/10.1530/eje.0.1470515
Herrman MF, Livolsi VA, Pasha TL, et al. Immunohistochemical expression of galectins-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med. 2002;126: 710-113. DOI: https://doi.org/10.5858/2002-126-0710-IEOGIB
Saleh HA, Feng J, Tabassum F, Al-Zohaili O, Husain M, Giorgadze T. Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy. CytoJournal. 2009; 6:18 DOI: https://doi.org/10.4103/1742-6413.55894
Martins L, Matsuo S, Ebina K, Kulcar M, Friguglietti C, Kimura E. Galectin-3 Messenger Ribonucleic Acid and Protein Are Expressed in Benign Thyroid Tumors. J Clin Endocrinol & Metabol. 2002;87: 4806-4810. DOI: https://doi.org/10.1210/jc.2002-020094
Collet JF, Hurbain I, Prengel C, Utzmann O, Scetbon F, Bernaudin JF, Fajac A. Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples. Brit J Cancer. 2005;93: 1175-1181. DOI: https://doi.org/10.1038/sj.bjc.6602822
Wang DL, Kane SS,Darresso AK. Computerized nuclear DNA in thyroid follicular carcinoma. World J Surg Oncol. 2006;4:65-87. DOI: https://doi.org/10.1186/1477-7819-4-65
Ismail RS, Mahfouz SM, Abd elfattah SL, Hussien H. Image cytometry of FNA of thyroid epithelial lesions. Thesis Cairo University, 2007.
Aron M, Kaplia K, Verma K. Utility of galectins-3 expression in thyroid aspirates as a diagnostic marker in differentiating bengin from malignant thyroid neoplasms. Indian J Pathol Microbiol. 2006;49: 376-380.
Nguyen GK, Lee, MW, Ginsberg J, Wragg T, Bilodeau D. Fine-needle aspiration of the thyroid: an overview. Cytojournal. 2005; 2: 12. DOI: https://doi.org/10.1186/1742-6413-2-12
Downloads
Published
How to Cite
Issue
Section
License
http://creativecommons.org/licenses/by-nc/4.0
